Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 43

Daily Deal Round Up: July 22, 2021

Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

Jul 22, 2021

Daily Deal Round Up: July 21, 2021

6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.

Jul 21, 2021

Tilting Point takes in $235m

Red Ventures has made a strategic investment in Tilting Point as part of the video game publishers’ first equity funding round.

Jul 21, 2021

GMA Network sets up venture unit

The media company will execute investments, strategic partnerships and M&A deals through newly formed holding vehicle GMA Ventures.

Jul 20, 2021

Daily Deal Round Up: July 19, 2021

Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.

Jul 19, 2021

Inshorts pockets $60m in funding

The BCC and SIG-backed news aggregator was valued at about $550m in a round led by technology investment firm Vy Capital.

Jul 19, 2021

Daily Deal Round Up: July 15, 2021

Clean medicine developer Genexa roped in Unilever for its $60m series A round while Krafton led storytelling platform developer Pratilipi's $48m series D.

Jul 15, 2021

Daily Deal Round Up: July 13, 2021

Lilith Games helped artificial intelligence software developer Inspir.ai secure $46.3m while Microsoft AI spinoff Xiaoice closed its series A round at a billion-dollar valuation.

Jul 13, 2021

Ravenage flies to $20m fund

The video game publisher’s investment vehicle will back indie game creators with the potential for long-term collaborations.

Jul 13, 2021

Daily Deal Round Up: July 9, 2021

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

Jul 9, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here